MedTrace Logo

Protein S100B Versus Neutrophils/Lymphocytes Ratio in Early Prediction of Brain Injury

NCT07093723 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2025-07-30

No results posted yet for this study

Summary

The study aimed to evaluate the role of Protein S100B versus the neutrophil-to-lymphocyte ratio (NLR) as an early predictor biomarker and the value of amplitude-integrated electroencephalography (aEEG) as an early predictor and prognostic method for neonatal brain injury susceptibility and severity.

Conditions

  • S100B
  • Neutrophils/Lymphocytes Ratio
  • Prediction
  • Brain Injury

Interventions

DIAGNOSTIC_TEST

S100B Protein

Serum level of S100B Protein was measured on the first and third days of seizure activity by ELISA.

DIAGNOSTIC_TEST

Neutrophils to Lymphocytes ratio

Neutrophils to Lymphocytes ratio was measured on the first and third day of seizure activity obtained by complete blood count.

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Eligibility

Min Age
28 Weeks
Max Age
36 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2024-03-01
Completion
2024-03-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07093723 on ClinicalTrials.gov